Skip to main content
Top
Published in: The European Journal of Health Economics 1/2008

01-02-2008 | Original paper

Factors influencing hospital costs of lung cancer patients in Northern Ireland

Authors: Ian Fleming, Pauline Monaghan, Anna Gavin, Ciaran O’Neill

Published in: The European Journal of Health Economics | Issue 1/2008

Login to get access

Abstract

Lung cancer is a major cause of morbidity and mortality. In this paper, the hospital costs incurred by 724 lung cancer patients diagnosed in 2001 were determined by review of case notes. These represented all patients diagnosed with lung cancer in Northern Ireland on whom data existed in that year. Total hospital costs in the 12 months from presentation for the 724 patients were £3.99 million. Average patient costs were £5,956 for patients diagnosed with non-small cell lung cancer and £5,876 for those with small cell lung cancer. The main component of cost was inpatient stay, representing between 62 and 84% of costs depending on cell type. Multivariate analyses revealed significant differences in cost related to staging, co-morbidities, age, and deprivation. Total annual hospital costs were 13 times as high as the estimated enforcement cost of the smoke-free legislation in Northern Ireland.
Footnotes
1
The NICR is a population-based registry providing comprehensive cancer information for the entire population of Northern Ireland.
 
Literature
1.
go back to reference Yuen, P.: Compendium of Health Statistics. OHE, London (2005) Yuen, P.: Compendium of Health Statistics. OHE, London (2005)
2.
go back to reference Cancer Research UK: CancerStats 2005, March, Cancer Research UK, London Cancer Research UK: CancerStats 2005, March, Cancer Research UK, London
3.
go back to reference Doll, R., Peto, R.: The Causes of Cancer, pp. 1220–1256. Oxford University Press, New York (1982) Doll, R., Peto, R.: The Causes of Cancer, pp. 1220–1256. Oxford University Press, New York (1982)
4.
go back to reference Souhami, R., Tobias, J.: Cancer and its Management. Blackewell Science, Oxford, pp 179–197 (2003) Souhami, R., Tobias, J.: Cancer and its Management. Blackewell Science, Oxford, pp 179–197 (2003)
5.
go back to reference Fitzpatrick, D., Gavin, A., Middleton, R., Catney, D.: Cancer in Northern Ireland 1993–2001. A Comprehensive Report, Northern Ireland Cancer Registry (2004) Fitzpatrick, D., Gavin, A., Middleton, R., Catney, D.: Cancer in Northern Ireland 1993–2001. A Comprehensive Report, Northern Ireland Cancer Registry (2004)
6.
go back to reference Jett, J.R., Midthun, D.E.: Screening for lung cancer: current status and future directions: Thomas A. Neff lecture. Chest 125(5 Suppl), 158S–162S (2004) Jett, J.R., Midthun, D.E.: Screening for lung cancer: current status and future directions: Thomas A. Neff lecture. Chest 125(5 Suppl), 158S–162S (2004)
7.
go back to reference Manser, R.: Screening for lung cancer: a review. Curr. Opin. Pulm. Med. 10, 266–271 (2004)CrossRef Manser, R.: Screening for lung cancer: a review. Curr. Opin. Pulm. Med. 10, 266–271 (2004)CrossRef
8.
go back to reference Ashton, R.W., Jett, J.R.: Screening for non-small cell lung cancer. Semin. Oncol. 32, 253–258 (2005)CrossRef Ashton, R.W., Jett, J.R.: Screening for non-small cell lung cancer. Semin. Oncol. 32, 253–258 (2005)CrossRef
9.
go back to reference Rossi, A., Maione, P., Colantuoni, G., Gaizo, F.D., Guerriero, C., Nicolella, D., Ferrara, C., Gridelli, C.: Screening for lung cancer: new horizons? Crit. Rev. Oncol. Hematol. 56, 311–320 (2005)CrossRef Rossi, A., Maione, P., Colantuoni, G., Gaizo, F.D., Guerriero, C., Nicolella, D., Ferrara, C., Gridelli, C.: Screening for lung cancer: new horizons? Crit. Rev. Oncol. Hematol. 56, 311–320 (2005)CrossRef
10.
go back to reference Goodwin, P.J., Feld, R., Evans, W.K., Pater, J.: Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. J. Clin. Oncol. 6, 1537–1547 (1988) Goodwin, P.J., Feld, R., Evans, W.K., Pater, J.: Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. J. Clin. Oncol. 6, 1537–1547 (1988)
11.
go back to reference Evans, W.K., Will, B.P., Berthelot, J.M., Wolfson, M.C.: Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM Model. Can. J. Oncol. 5, 408–419 (1995) Evans, W.K., Will, B.P., Berthelot, J.M., Wolfson, M.C.: Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM Model. Can. J. Oncol. 5, 408–419 (1995)
12.
go back to reference Oliver, E., Killen, J., Kiebert, G., Hutton, J., Hall, R., Higgins, B., Bourke, S., Paschen, B.: Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax 56, 785–790 (2001)CrossRef Oliver, E., Killen, J., Kiebert, G., Hutton, J., Hall, R., Higgins, B., Bourke, S., Paschen, B.: Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax 56, 785–790 (2001)CrossRef
13.
go back to reference Dedes, K.J., Szucs, T.D., Bodis, S., Joerger, M., Lowy, A., Russi, E.W., Steinert, H.C., Weder, W., Stahel, R.A.: Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics 22, 435–444 (2004)CrossRef Dedes, K.J., Szucs, T.D., Bodis, S., Joerger, M., Lowy, A., Russi, E.W., Steinert, H.C., Weder, W., Stahel, R.A.: Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics 22, 435–444 (2004)CrossRef
14.
go back to reference Wolstenholme, J.L., Whynes, D.K.: The hospital costs of treating lung cancer in the United Kingdom. Br. J. Cancer 80, 215–218 (1999)CrossRef Wolstenholme, J.L., Whynes, D.K.: The hospital costs of treating lung cancer in the United Kingdom. Br. J. Cancer 80, 215–218 (1999)CrossRef
15.
go back to reference British Medical Association and Royal Pharmaceutical Society of Great Britain: Br. Natl Formul. 48, 384–410 (2004) British Medical Association and Royal Pharmaceutical Society of Great Britain: Br. Natl Formul. 48, 384–410 (2004)
16.
go back to reference Charlson, M.E., Pompei, P., Ales, K.L., Mackenzie, C.R.: A new method of classifying prognostic comorbidit in longtidinal studies: development and validation. J. Chronic. Dis. 40, 373–383 (1987)CrossRef Charlson, M.E., Pompei, P., Ales, K.L., Mackenzie, C.R.: A new method of classifying prognostic comorbidit in longtidinal studies: development and validation. J. Chronic. Dis. 40, 373–383 (1987)CrossRef
17.
go back to reference Nodel, M., Smith, G., Wright, G., Dibben, C., Lloyd, M., Shuttleworth, I.: Measures of Deprivation in Northern Ireland. Social Disadvantage Research Centre University of Oxford (2001) Nodel, M., Smith, G., Wright, G., Dibben, C., Lloyd, M., Shuttleworth, I.: Measures of Deprivation in Northern Ireland. Social Disadvantage Research Centre University of Oxford (2001)
19.
go back to reference Deppermann, K.M.: Lung cancer screening—where we are in 2004 (take home messages). Lung Cancer 45(Suppl), S39–S42 (2004)CrossRef Deppermann, K.M.: Lung cancer screening—where we are in 2004 (take home messages). Lung Cancer 45(Suppl), S39–S42 (2004)CrossRef
20.
go back to reference Jarvis, M.J.: A profile of tobacco smoking. Addiction 89, 1371–1376 (1994)CrossRef Jarvis, M.J.: A profile of tobacco smoking. Addiction 89, 1371–1376 (1994)CrossRef
21.
go back to reference Wardle, J., Jarvis, M.J., Steggles, N., Sutton, S., Williamson, S., Farrimond, H., Cartwright, M., Simon, A.E.: Socioeconomic disparities in cancer-risk behaviors in adolescence: baseline results from the Health and Behaviour in Teenagers Study (HABITS). Prev. Med. 36, 721–730 (2003)CrossRef Wardle, J., Jarvis, M.J., Steggles, N., Sutton, S., Williamson, S., Farrimond, H., Cartwright, M., Simon, A.E.: Socioeconomic disparities in cancer-risk behaviors in adolescence: baseline results from the Health and Behaviour in Teenagers Study (HABITS). Prev. Med. 36, 721–730 (2003)CrossRef
22.
go back to reference Department of Health, Social Services and Public Safety Northern Ireland: The Smoking Order Consultation, pp. 64–72. DHSS &PS, Northern Ireland (2006) Department of Health, Social Services and Public Safety Northern Ireland: The Smoking Order Consultation, pp. 64–72. DHSS &PS, Northern Ireland (2006)
Metadata
Title
Factors influencing hospital costs of lung cancer patients in Northern Ireland
Authors
Ian Fleming
Pauline Monaghan
Anna Gavin
Ciaran O’Neill
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 1/2008
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-007-0047-4

Other articles of this Issue 1/2008

The European Journal of Health Economics 1/2008 Go to the issue

Pricing and reimbursement systems in Europe

Pharmaceutical pricing and reimbursement reforms in Greece